Individualising MHT: Australian and NZ perspectives

Dr Elina Safro¹, Dr Janice Brown²

¹Family Planning Australia, ²Auckland University

The session aim to address the following factors impacting the use of MHT:

1. Clinician confidence and clarity in prescribing (we’re going to demonstrate various non-oral options and discuss the FAQs for which we don’t have evidence-based guidelines)
2. Patient preference – (discretion, ease of use, cost)
3. Scope for incorrect use (including fixed-dose preparations)
4. Keeping up to date with availability and cost